ahlam1399
09-20-2016, 05:12 AM
UPDATE 3-Bowing to pressure, U.S. FDA approves Sarepta?s Duchenne drug
Sept 19 (Reuters) - Bowing to pressure from patientadvocates, the U.S. Food and Drug Administration on Mondayapproved a treatment for Duchenne muscular dystrophy even thoughan outside panel of...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=AC0OEBPOrjc:un0wWlLLbQQ:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=AC0OEBPOrjc:un0wWlLLbQQ:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/AC0OEBPOrjc
Sept 19 (Reuters) - Bowing to pressure from patientadvocates, the U.S. Food and Drug Administration on Mondayapproved a treatment for Duchenne muscular dystrophy even thoughan outside panel of...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=AC0OEBPOrjc:un0wWlLLbQQ:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=AC0OEBPOrjc:un0wWlLLbQQ:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=AC0OEBPOrjc:un0wWlLLbQQ:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/AC0OEBPOrjc